Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncology
Join Drs. Eytan Ruppin (presenter) and Timothy Shaw (moderator) as they present on four approaches for predicting how patients respond to checkpoint immunotherapy.
- Approach #1: Predicting patient response to the tumor bulk transcriptome
- Approach #2: Predicting response directly from the blood via simple routine lab tests and the tumor mutational burden
- Approach #3: Predicting patient immunotherapy response from the tumor histopathological images
- Approach #4: Building predictors of the tumor microenvironment and developing spatially grounded biomarkers of treatment response
This webinar is part of the 2025 SITC-NCI Computational Immuno-oncology Webinar Series, which is focusing on methods and clinical utility for biomarker development in immune-oncology. This is the fifth of ten free webinars set to help individual research labs overcome the computational challenges of analyzing and integrating different assay data throughout the spectrum of immuno-oncology for biomarker development. The annual series aims to educate early-career scientists, increase participants’ awareness of and engagement in NCI-supported Immunotherapy Networks, and fulfill the goal of accelerating progress in cancer research.
Dr. Ruppin is the chief and senior investigator of NCI’s Cancer Data Science Laboratory.
Dr. Timothy Shaw is an assistant member in the Department of Biostatistics and Bioinformatics at the Moffitt Cancer Center.
Upcoming Events
-
Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncologyJuly 08, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025Childhood Cancer Data Initiative (CCDI) Symposium 2025October 06, 2025 - October 07, 2025